These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21625618)

  • 21. SUP35 expression is enhanced in yeast containing [ISP+], a prion form of the transcriptional regulator Sfp1.
    Radchenko E; Rogoza T; Khokhrina M; Drozdova P; Mironova L
    Prion; 2011; 5(4):317-22. PubMed ID: 22156729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Appearance and propagation of polyglutamine-based amyloids in yeast: tyrosine residues enable polymer fragmentation.
    Alexandrov IM; Vishnevskaya AB; Ter-Avanesyan MD; Kushnirov VV
    J Biol Chem; 2008 May; 283(22):15185-92. PubMed ID: 18381282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions among prions and prion "strains" in yeast.
    Bradley ME; Edskes HK; Hong JY; Wickner RB; Liebman SW
    Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16392-9. PubMed ID: 12149514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-terminal truncation of the Sup35 protein increases the frequency of de novo generation of a prion-based [PSI+] determinant in Saccharomyces cerevisiae.
    Kochneva-Pervukhova NV; Poznyakovski AI; Smirnov VN; Ter-Avanesyan MD
    Curr Genet; 1998 Aug; 34(2):146-51. PubMed ID: 9724418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prion-Associated Toxicity is Rescued by Elimination of Cotranslational Chaperones.
    Keefer KM; True HL
    PLoS Genet; 2016 Nov; 12(11):e1006431. PubMed ID: 27828954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De novo [PSI
    Sharma J; Wisniewski BT; Paulson E; Obaoye JO; Merrill SJ; Manogaran AL
    Sci Rep; 2017 Mar; 7(1):76. PubMed ID: 28250435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Sup35 domains required for maintenance of weak, strong or undifferentiated yeast [PSI+] prions.
    Bradley ME; Liebman SW
    Mol Microbiol; 2004 Mar; 51(6):1649-59. PubMed ID: 15009892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of pre-existing aggregates in Hsp104-dependent polyglutamine aggregate formation and epigenetic change of yeast prions.
    Kimura Y; Koitabashi S; Kakizuka A; Fujita T
    Genes Cells; 2004 Aug; 9(8):685-96. PubMed ID: 15298677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of prion-destabilizing mutations in the N-terminal non-prion domain of Rnq1 in Saccharomyces cerevisiae.
    Shibata S; Kurahashi H; Nakamura Y
    Prion; 2009; 3(4):250-8. PubMed ID: 20009538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress conditions increase the frequency of de novo formation of the yeast [PSI+] prion.
    Doronina VA; Staniforth GL; Speldewinde SH; Tuite MF; Grant CM
    Mol Microbiol; 2015 Apr; 96(1):163-74. PubMed ID: 25601439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selfish prion of Rnq1 mutant in yeast.
    Kurahashi H; Shibata S; Ishiwata M; Nakamura Y
    Genes Cells; 2009 May; 14(5):659-68. PubMed ID: 19371377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic study of interactions between the cytoskeletal assembly protein sla1 and prion-forming domain of the release factor Sup35 (eRF3) in Saccharomyces cerevisiae.
    Bailleul PA; Newnam GP; Steenbergen JN; Chernoff YO
    Genetics; 1999 Sep; 153(1):81-94. PubMed ID: 10471702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the N-terminal oligopeptide repeats of the yeast Sup35 prion protein in propagation and transmission of prion variants.
    Shkundina IS; Kushnirov VV; Tuite MF; Ter-Avanesyan MD
    Genetics; 2006 Feb; 172(2):827-35. PubMed ID: 16272413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [PSI(+) ] prion variant establishment in yeast.
    Sharma J; Liebman SW
    Mol Microbiol; 2012 Nov; 86(4):866-81. PubMed ID: 22998111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of prion-dependent polyglutamine aggregation and toxicity by chaperone proteins in the yeast model.
    Gokhale KC; Newnam GP; Sherman MY; Chernoff YO
    J Biol Chem; 2005 Jun; 280(24):22809-18. PubMed ID: 15824100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heat shock protein 104 (Hsp104)-mediated curing of [
    Zhao X; Rodriguez R; Silberman RE; Ahearn JM; Saidha S; Cummins KC; Eisenberg E; Greene LE
    J Biol Chem; 2017 May; 292(21):8630-8641. PubMed ID: 28373280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yeast Sup35 Prion Structure: Two Types, Four Parts, Many Variants.
    Dergalev AA; Alexandrov AI; Ivannikov RI; Ter-Avanesyan MD; Kushnirov VV
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DMSO-mediated curing of several yeast prion variants involves Hsp104 expression and protein solubilization, and is decreased in several autophagy related gene (atg) mutants.
    Dorweiler JE; Obaoye JO; Oddo MJ; Shilati FM; Scheidemantle GM; Coleman TJ; Reilly JA; Smith GR; Manogaran AL
    PLoS One; 2020; 15(3):e0229796. PubMed ID: 32134970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonistic interactions between yeast [PSI(+)] and [URE3] prions and curing of [URE3] by Hsp70 protein chaperone Ssa1p but not by Ssa2p.
    Schwimmer C; Masison DC
    Mol Cell Biol; 2002 Jun; 22(11):3590-8. PubMed ID: 11997496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new perspective on Hsp104-mediated propagation and curing of the yeast prion [PSI (+) ].
    Helsen CW; Glover JR
    Prion; 2012 Jul; 6(3):234-9. PubMed ID: 22561166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.